Ledger.Open graph →
SEC Form D · Amendment · filed September 14, 2016

Revitope Oncology, Inc

Offering
$8.2M
Sold
$8.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Andrew Allen · San Francisco, CAExec · DirectorMark Cobbold · San Francisco, CADirectorJulie Cherrington · San Francisco, CAExec · DirectorRaj Mehta · San Francisco, CADirectorPeter Joost · San Francisco, CADirectorAndrew Allen · Orlando, FLExec · DirectorMark Cobbold · San Francisco, CADirectorJulie Cherrington · San Francisco, CAExec · DirectorRaj Mehta · San Francisco, CADirectorPeter Joost · San Francisco, CADirectorAndrew Allen · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗